These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7731679

  • 21. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS, Zwiebel JA, Noda M, Bassin RH.
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [Abstract] [Full Text] [Related]

  • 22. Effect of transforming growth factor beta on rat hepatocyte cell lines depends upon the state of tumorigenic progression.
    Reeder MK, Isom HC.
    Cell Growth Differ; 1996 Apr; 7(4):449-60. PubMed ID: 9052986
    [Abstract] [Full Text] [Related]

  • 23. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P, Kidwell WR.
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Transforming growth factor production by chemically transformed cells.
    Moses HL, Branum EL, Proper JA, Robinson RA.
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [Abstract] [Full Text] [Related]

  • 28. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
    Vennström B, Bravo R.
    Oncogene; 1987 Jul; 1(3):271-6. PubMed ID: 3330775
    [Abstract] [Full Text] [Related]

  • 29. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
    Huber BE, Cordingley MG.
    Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790
    [Abstract] [Full Text] [Related]

  • 30. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
    Surmacz E, Sell C, Swantek J, Kato H, Roberts CT, LeRoith D, Baserga R.
    Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
    [Abstract] [Full Text] [Related]

  • 31. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J, Jiang B, Coffey RJ, Barnard J.
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [Abstract] [Full Text] [Related]

  • 32. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ, Song R, Korkola JE, Archer MC, Ben-David Y.
    Oncogene; 2003 May 29; 22(22):3452-62. PubMed ID: 12776197
    [Abstract] [Full Text] [Related]

  • 33. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ, Austin VN, Zimmer SG, Fisher PB.
    Oncogene; 1993 May 29; 8(5):1211-9. PubMed ID: 8479744
    [Abstract] [Full Text] [Related]

  • 34. Overexpression of PKCepsilon in R6 fibroblasts causes increased production of active TGFbeta.
    Cacace AM, Ueffing M, Han EK, Marmè D, Weinstein IB.
    J Cell Physiol; 1998 Jun 29; 175(3):314-22. PubMed ID: 9572476
    [Abstract] [Full Text] [Related]

  • 35. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
    Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A.
    Oncogene; 1991 Aug 29; 6(8):1465-70. PubMed ID: 1886717
    [Abstract] [Full Text] [Related]

  • 36. Cytoplasmic pH and anchorage-independent growth induced by v-Ki-ras, v-src or polyoma middle T.
    Schwartz MA, Rupp EE, Frangioni JV, Lechene CP.
    Oncogene; 1990 Jan 29; 5(1):55-8. PubMed ID: 2181378
    [Abstract] [Full Text] [Related]

  • 37. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
    Houck KA, Michalopoulos GK, Strom SC.
    Oncogene; 1989 Jan 29; 4(1):19-25. PubMed ID: 2783773
    [Abstract] [Full Text] [Related]

  • 38. Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines.
    Guo M, Reiners JJ.
    Carcinogenesis; 2000 Jul 29; 21(7):1303-12. PubMed ID: 10874007
    [Abstract] [Full Text] [Related]

  • 39. Evidence for cell-specific differences in transformation by N-, H- and K-ras.
    Maher J, Baker DA, Manning M, Dibb NJ, Roberts IA.
    Oncogene; 1995 Oct 19; 11(8):1639-47. PubMed ID: 7478589
    [Abstract] [Full Text] [Related]

  • 40. A beta-type transforming growth factor, present in conditioned cell culture medium independent of cell transformation, may derive from serum.
    Stromberg K, Twardzik DR.
    J Cell Biochem; 1985 Oct 19; 27(4):443-8. PubMed ID: 2987278
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.